OtherShort Communication
The contributions of cytochrome P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors (PDE5Is) sildenafil, udenafil, and vardenafil
Hei-Young Ku, Hee-Jeong Ahn, Kyung-Ah Seo, Hyunmi Kim, Minkyung Oh, Soo Kyung Bae, Jae-Gook Shin, Ji-Hong Shon and Kwang-Hyeon Liu
Drug Metabolism and Disposition February 28, 2008, DOI: https://doi.org/10.1124/dmd.107.020099
Hei-Young Ku
Hee-Jeong Ahn
Kyung-Ah Seo
Hyunmi Kim
Minkyung Oh
Soo Kyung Bae
Jae-Gook Shin
Ji-Hong Shon
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherShort Communication
The contributions of cytochrome P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors (PDE5Is) sildenafil, udenafil, and vardenafil
Hei-Young Ku, Hee-Jeong Ahn, Kyung-Ah Seo, Hyunmi Kim, Minkyung Oh, Soo Kyung Bae, Jae-Gook Shin, Ji-Hong Shon and Kwang-Hyeon Liu
Drug Metabolism and Disposition February 28, 2008, DOI: https://doi.org/10.1124/dmd.107.020099
OtherShort Communication
The contributions of cytochrome P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors (PDE5Is) sildenafil, udenafil, and vardenafil
Hei-Young Ku, Hee-Jeong Ahn, Kyung-Ah Seo, Hyunmi Kim, Minkyung Oh, Soo Kyung Bae, Jae-Gook Shin, Ji-Hong Shon and Kwang-Hyeon Liu
Drug Metabolism and Disposition February 28, 2008, DOI: https://doi.org/10.1124/dmd.107.020099
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement